Literature DB >> 1317247

Efficacy of antiserum produced in goats and pigs to passively protect piglets against virulent transmissible gastroenteritis virus.

R D Woods1, R D Wesley.   

Abstract

The protective effect of sera produced in swine and goats exposed to virulent transmissible gastroenteritis virus (TGEV) or modified-live TGEV was tested in hysterectomy-derived, colostrum-deprived three-day-old pigs. Pigs were given serum with their daily ration of milk, and their immunity to virulent TGEV was determined. The pigs were observed for ten days for clinical signs of TGEV infection. One of nine pigs receiving goat serum was protected whereas all three pigs receiving three doses of swine serum per day were protected. Because virus was not isolated from the goats after oral/intranasal vaccination, it is suggested the virus did not replicate in either the respiratory or digestive tract of the goat.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317247      PMCID: PMC1263528     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  9 in total

1.  Transmissible gastroenteritis of swine; a study of immunity.

Authors:  W W BAY; L P DOYLE; L M HUTCHINIGS
Journal:  J Am Vet Med Assoc       Date:  1953-03       Impact factor: 1.936

2.  Efficacy of isolated colostral IgA, IgG, and IgM(A) to protect neonatal pigs against the coronavirus of transmissible gastroenteritis.

Authors:  S S Stone; L J Kemeny; R D Woods; M T Jensen
Journal:  Am J Vet Res       Date:  1977-09       Impact factor: 1.156

3.  Studies on transmissible gastroenteritis of swine. II. Selected characteristics of a cytopathogenic virus common to five isolates from transmissible gastroenteritis.

Authors:  A W McClurkin; J O Norman
Journal:  Can J Comp Med Vet Sci       Date:  1966-07

4.  Passive immunity in transmissible gastroenteritis of swine: immunoglobulin characteristics of antibodies in milk after inoculating virus by different routes.

Authors:  E H Bohl; L J Saif
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

5.  Use of polyvalent cow colostrum in the prevention of enteric infections in calves and piglets.

Authors:  J Mensík; E Salajka; J Stĕpánek; L Ulmann; Z Procházka; J Dressler
Journal:  Ann Rech Vet       Date:  1978

6.  Antibody responses in serum, colostrum, and milk of swine after infection or vaccination with transmissible gastroenteritis virus.

Authors:  E H Bohl; R K Gupta; M V Olquin; L J Saif
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

7.  Coronaviridae.

Authors:  S G Siddell; R Anderson; D Cavanagh; K Fujiwara; H D Klenk; M R Macnaughton; M Pensaert; S A Stohlman; L Sturman; B A van der Zeijst
Journal:  Intervirology       Date:  1983       Impact factor: 1.763

8.  A viral subunit immunogen for porcine transmissible gastroenteritis.

Authors:  P M Gough; C H Ellis; C J Frank; C J Johnson
Journal:  Antiviral Res       Date:  1983-09       Impact factor: 5.970

9.  Lack of protection in vivo with neutralizing monoclonal antibodies to transmissible gastroenteritis virus.

Authors:  R D Wesley; R D Woods; I Correa; L Enjuanes
Journal:  Vet Microbiol       Date:  1988-12       Impact factor: 3.293

  9 in total
  3 in total

1.  Passive protection of piglets by recombinant baculovirus induced transmissible gastroenteritis virus specific antibodies.

Authors:  T Tuboly; E Nagy; J B Derbyshire
Journal:  Can J Vet Res       Date:  1995-01       Impact factor: 1.310

2.  Novel small-molecule inhibitors of transmissible gastroenteritis virus.

Authors:  Cheng-Wei Yang; Yung-Ning Yang; Po-Huang Liang; Chi-Min Chen; Wei-Liang Chen; Hwan-You Chang; Yu-Sheng Chao; Shiow-Ju Lee
Journal:  Antimicrob Agents Chemother       Date:  2007-08-20       Impact factor: 5.191

Review 3.  Immunity to transmissible gastroenteritis virus and porcine respiratory coronavirus infections in swine.

Authors:  L J Saif; J L van Cott; T A Brim
Journal:  Vet Immunol Immunopathol       Date:  1994-10       Impact factor: 2.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.